FDA approves ColoSense – a noninvasive multi-target stool RNA (mt-sRNA) colorectal cancer screening test – Geneoscopy Inc
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced that the FDA approved its noninvasive colorectal cancer screening test,… read more.
